Thermo Fisher Scientific Acquires PPD 2021

Thermo Fisher Scientific announced the acquisition of PPD, a leading Clinical Research Organization, for $17.4 billion in cash plus $3.5 billion in net debt assumption. The acquisition extends Thermo Fisher's capabilities for pharmaceutical and biotech customers and is expected to be immediately and significantly accretive to adjusted EPS within the first twelve months post-close.